It is likely that the neuroprotective effects of MAGL inactivation are mediated through resolving neuroinflammation, which, in turn, mitigates neuropathology and prevents synaptic and cognitive declines in neurodegenerative diseases [36]. This evidence concerns the gene MGLL and neurodegenerative disease.